Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Who is selling shares at 4 1/2 cents presplit. The trial news should be amazing for the share price!
The lancet made up a lie about hydroxychloroquine, I don't trust their report on cytosorb!
The Lancet Retracts Hydroxychloroquine Study
By Ralph Ellis
woman holding pill
June 4, 2020 - The online medical journal The Lancet has apologized to readers after retracting a study that said the anti-malarial drug hydroxychloroquine did not help to curb COVID-19 and might cause death in patients.
The study was withdrawn because the company that provided data would not provide full access to the information for a third-party peer review, saying to do so would violate client agreements and confidentiality requirements, The Lancet said in a statement.
“Based on this development, we can no longer vouch for the veracity of the primary data sources.
The Biocon Group is catering to the countrywide demand for Remdesivir, Itolizumab and CytoSorb.
Might be a little shakeup coming!
Not sure but thanks for the info!
a lot of stocks I follow had a large trade at the close.
I follow 36 stocks, today's average decline 9%, want are you gonna do? CTSO 4%
Best liver dialysis treatment on the market, Cytosorb filter, Chan stated!
Down around 19% from the high of $11.68 on the 4th of Feb, after all that wonderful buying! Good luck with your new shares!
Release the Remove read out, Chan!
Positive read out on the Remove study, will help jump start the ctso train! Chan stated in the last minute of presentation, Remove "read out very soon"!
Last April, we achieved FDA Breakthrough Designation of CytoSorb to remove ticagrelor during urgent or emergent cardiothoracic surgery. However, expectedly, the Agency focused on the pandemic which significantly delayed the FDA's availability to advance non-COVID-19 applications. That said, we recently just met again with the Agency and believe that we are now aligned on the positive benefit-risk profile of the therapy and the additional clinical data needed to support approval.
"That said, we recently just met again with the Agency"
Whine about no s/h letter and now whine about the contents of the s/h letter! You want to help the s/p, buy more shares!
Lot of resistance around $11.50, need more buyers! IMHO
Good day today. Stock still makes me feel like I am treading water with 50lbs of weight tied to my legs!
Let it run!
It is about time!! We catch a break!
$10.78 currently?
keep it coming, what ever it is!
the spike from the BlackRock news?
over 200,000 shares in a few minutes!
what's with the big spike in s/p and volume?
TwoNE1, you are right, my bad!!!
1200 covid patience treated in Iran in the month of September!
Crazy! Thanks for sharing!
Since you sold a few weeks ago, I personally am not interested in your opinion!fwiw
In shock that it didn't sell off the last hour!
Trading step in step with the NASDAQ going down! Funny how that works, sure doesn't trade step in step up!
Sell more filters and less shares!
Great! Buying opportunity number 1000, since the date I originally bought in!
I didn't realize we are a tech stock!
If all retail is trimming their position in a stock that only trades around 375,000 shares, you get an $8 stock! No more wondering why the stock is trending lower!
"it seems we have to wait another couple of years before we get rewarded" I personally would be long gone, if I felt that way!
Earnings were in line with my expectations. Selling shares $2.00 below current s/p never helps!
My point is, we were heading to a $12 s/p, now we are heading to a $7 s/p and the markets are at an all time high! At least we have $89 million in the coffers!
One month = 28% drop from $11.74! Markets at all time highs!
accumulation on the sly, b.s.! after the run up this morning!
$CTSO "That said, we have not historically given specific financial guidance on quarterly results until the quarter has been completed. However, notwithstanding uncertainty related to the COVID-19 pandemic, based upon current order patterns, we expect that Q3 2020 will be one of the company's strongest quarters in terms of product sales."
Actually I don't. Others were complaining about no pr until today. That is what happens when you have such good researchers on this message board, find material events before official pr's.
Why would the company pr an awarded contract before the contract was officially signed? They wouldn't!
Buyout or partnership?
On yahoo conversation I found. 5 hours ago
Just got through reading the prospectus. @CG any thoughts on why the gross margin fell a whopping 6% to 70% during the quarter? There are not a lot of studies going on where the filters would hit the cost of those trials. Also, another noteworthy tidbit buried in the prospectus is that the REMOVE trial analysis of the study data and issuance of the study report has been delayed to now the second half of the year (potentially Q3) due to Covid-19. Not on stockwits. You had me looking in the wrong direction!